Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $15 | $17 | $15 |
| % Growth | -99.2% | -14.1% | 13.8% | – |
| Cost of Goods Sold | $0 | $8 | $12 | $8 |
| Gross Profit | $0 | $7 | $5 | $7 |
| % Margin | 42.8% | 45.1% | 29.4% | 45.2% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $0 | $4 | $1 | $4 |
| SG&A Expenses | $0 | $4 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $5 | $3 | $5 |
| Operating Income | $0 | $2 | $2 | $2 |
| % Margin | 8.7% | 11.6% | 12.5% | 10.1% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | $0 | $2 | $2 | $2 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | $0 | $1 | $2 | $1 |
| % Margin | 7.2% | 9.5% | 8.9% | 8.7% |
| EPS | 0.3 | 49.48 | 53.97 | 46.39 |
| % Growth | -99.4% | -8.3% | 16.3% | – |
| EPS Diluted | 0.3 | 49.48 | 53.97 | 46.39 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $2 | $2 | $2 |
| % Margin | 10.2% | 12.3% | 13.1% | 11.9% |